<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Gubra — Januar 2026]]></title><description><![CDATA[<p dir="auto">Gubra udpeger ny direktør for medicin og udvikling <a href="https://proinvestor.com/investornyt/1399582/gubra-udpeger-ny-direktor-for-medicin-og-udvikling" rel="nofollow ugc">https://proinvestor.com/investornyt/1399582/gubra-udpeger-ny-direktor-for-medicin-og-udvikling</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/401332/gubra-januar-2026</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 22:23:29 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/401332.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 05 Jan 2026 06:03:02 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Gubra — Januar 2026 on Tue, 27 Jan 2026 07:09:27 GMT]]></title><description><![CDATA[<p dir="auto">OVERBLIK: Disse selskaber er shortet på det danske aktiemarked <a href="https://proinvestor.com/investornyt/1407306/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked" rel="nofollow ugc">https://proinvestor.com/investornyt/1407306/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8056047</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8056047</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 27 Jan 2026 07:09:27 GMT</pubDate></item><item><title><![CDATA[Reply to Gubra — Januar 2026 on Thu, 22 Jan 2026 08:28:50 GMT]]></title><description><![CDATA[<p dir="auto">Er der nogen der ved hvor længe der går før man kan forvente resultater fra amylinkandidaten med AbbVie? Mener da studiet er færdigt.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8056046</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8056046</guid><dc:creator><![CDATA[barrenwuffet]]></dc:creator><pubDate>Thu, 22 Jan 2026 08:28:50 GMT</pubDate></item><item><title><![CDATA[Reply to Gubra — Januar 2026 on Tue, 13 Jan 2026 05:19:25 GMT]]></title><description><![CDATA[<p dir="auto">Pfizer ser enormt potentiale på linje med Viagra i salg af fedmemedicin i håndkøb <a href="https://proinvestor.com/investornyt/1402363/pfizer-ser-enormt-potentiale-pa-linje-med-viagra-i-salg-af-fedmemedicin-i-handkob" rel="nofollow ugc">https://proinvestor.com/investornyt/1402363/pfizer-ser-enormt-potentiale-pa-linje-med-viagra-i-salg-af-fedmemedicin-i-handkob</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8056045</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8056045</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 13 Jan 2026 05:19:25 GMT</pubDate></item><item><title><![CDATA[Reply to Gubra — Januar 2026 on Thu, 08 Jan 2026 16:51:46 GMT]]></title><description><![CDATA[<p dir="auto">8/1 Medwatch "Amerikansk selskab løfter sløret for kandidat i Gubra-samarbejde<br />
Som følge af udvælgelsen står Gubra til at modtage 4 mio. dollar i milepælsbetaling svarende til cirka 26 mio. kr. " <a href="https://medwatch.dk/brancher/Medicinal___Biotek/article18901151.ece" rel="nofollow ugc">https://medwatch.dk/brancher/Medicinal___Biotek/article18901151.ece</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8056044</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8056044</guid><dc:creator><![CDATA[Cupcake]]></dc:creator><pubDate>Thu, 08 Jan 2026 16:51:46 GMT</pubDate></item></channel></rss>